Skip to main content

Peer Review reports

From: Exploring the mechanism of fraxetin against acute myeloid leukemia through cell experiments and network pharmacology

Original Submission
26 Mar 2023 Submitted Original manuscript
16 Jun 2023 Reviewed Reviewer Report - Song-Tao Wu
23 Jun 2023 Reviewed Reviewer Report
30 Jul 2023 Reviewed Reviewer Report
20 Aug 2023 Author responded Author comments - Wenjun Liu
Resubmission - Version 2
20 Aug 2023 Submitted Manuscript version 2
2 Sep 2023 Reviewed Reviewer Report
23 Nov 2023 Reviewed Reviewer Report
12 Dec 2023 Author responded Author comments - Wenjun Liu
Resubmission - Version 3
12 Dec 2023 Submitted Manuscript version 3
13 Dec 2023 Author responded Author comments - Wenjun Liu
Resubmission - Version 4
13 Dec 2023 Submitted Manuscript version 4
13 Dec 2023 Author responded Author comments - Wenjun Liu
Resubmission - Version 5
13 Dec 2023 Submitted Manuscript version 5
3 Feb 2024 Reviewed Reviewer Report
12 Mar 2024 Author responded Author comments - Wenjun Liu
Resubmission - Version 6
12 Mar 2024 Submitted Manuscript version 6
Publishing
30 May 2024 Editorially accepted
10 Jun 2024 Article published 10.1186/s12906-024-04529-8

You can find further information about peer review here.

Back to article page